share_log

Benchmark Reiterates Buy on Enovix, Maintains $25 Price Target

Benzinga ·  Oct 30 22:32  · Ratings

Benchmark analyst Michael Legg reiterates Enovix (NASDAQ:ENVX) with a Buy and maintains $25 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment